ReviewCancers2022
Alternative Treatment Options to ALK Inhibitor Monotherapy for EML4-ALK-Driven Lung Cancer.
Savvas Papageorgiou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
12 papers cite it
this papercites it
ReviewCancers2022
Savvas Papageorgiou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.